Key result
Partial splenectomy yields 15-month recurrence-free survival in a child with splenic hemangioendothelioma.
Case Report (n=1)
This case report demonstrates that partial splenectomy can be a successful treatment for rare splenic hemangioendothelioma in pediatric patients.
Primary hemangioendotheliomas (HEs) of the spleen are rare, low-grade borderline-malignant vascular tumors. To date, only a few splenic HE cases have been reported in adults. In infants, one 9-year-old male patient has previously been reported, and the patient succumbed to the disease shortly following surgery. Currently, the clinical treatment and prognosis of the disease remains challenging to define, due to the extremely low number of cases reported. The current report presents the case of a 9-year-old pediatric patient with splenic HE, who survived with no recurrence or complications following a partial splenectomy. Additionally, a literature review was conducted to analyze the treatment and prognosis of the disease.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2014) conducted a case report in Primary hemangioendothelioma of the spleen (n=1). Partial splenectomy was evaluated on Recurrence or complications. A 9-year-old female patient with splenic hemangioendothelioma survived with no recurrence or complications for 15 months following a partial splenectomy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: